Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001062993-15-003474
Filing Date
2015-06-19
Accepted
2015-06-19 17:14:11
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM POS AM posam.htm POS AM 876465
2 EXHIBIT 23.1 exhibit23-1.htm EX-23.1 1209
9 GRAPHIC posamx4x1.jpg GRAPHIC 3215
10 GRAPHIC consentx1x1.jpg GRAPHIC 1983
  Complete submission text file 0001062993-15-003474.txt   11776019

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE FILE avxl-20150331.xml EX-101.INS 1017962
4 XBRL SCHEMA FILE avxl-20150331.xsd EX-101.SCH 356118
5 XBRL CALCULATION FILE avxl-20150331_cal.xml EX-101.CAL 35699
6 XBRL DEFINITION FILE avxl-20150331_def.xml EX-101.DEF 837430
7 XBRL LABEL FILE avxl-20150331_lab.xml EX-101.LAB 2361676
8 XBRL PRESENTATION FILE avxl-20150331_pre.xml EX-101.PRE 922422
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: POS AM | Act: 33 | File No.: 333-191682 | Film No.: 15943068
SIC: 8731 Services-Commercial Physical & Biological Research